Remdesivir Didn't Cut Hospital Stay Or Mortality In Covid Patients: WHO

Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.

from NDTV News - Latest https://ift.tt/3nX8fwP
via